Procedure
venous sinus stenting
venous sinus stenting is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NCT05050864
completedphase_1
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
NCT01407809
completednot_applicable
The Effects of MAP and EtCO2 on Venous Sinus Pressures
NCT03867461
Clinical Trials (3)
Showing 3 of 3 trials
NCT05050864Not Applicable
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NCT01407809Phase 1
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
NCT03867461Not Applicable
The Effects of MAP and EtCO2 on Venous Sinus Pressures
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3